Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors

Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors

US Patent 7348003 · Granted Mar 25, 2008

Estimated economic value: $11,940,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific binding proteins and uses thereof2024
Antibodies directed against GDF-152023
Nucleic acids encoding anti-PAR2 antibodies and uses thereof2023
Bispecific binding proteins and uses thereof2022
Anti-PAR2 antibodies and uses thereof2020
Phage display library, members thereof and uses of the same2020
P2X4 antibodies and uses thereof2020
Human antibodies against eotaxin and their use2020
Bispecific binding proteins and uses thereof2019
Methods for binding members of interleukin-4 receptor α (IL-4Rα)2017
Albumin-insulin fusion proteins2016
Humanized antibodies against TL1A2016